Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

3.377 -0.133 (-3.79%)
Streaming Delayed Price Updated: 12:01 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
Prime Blockchain SPAC Merger? 15 Things to Know as VCXA Stock Surges Today
Crypto miner Prime Blockchain is reportedly in talks to go public via a SPAC merger with 10X Capital Venture Acquisition II (VCXA). 
Via InvestorPlace
CLOV Stock Alert: There’s a $300M Reason Clover Health Is Stumbling Today
Meme stock favorite Clover Health is under pressure today after announcing a new secondary stock offering that has upset investors. 
Via InvestorPlace
80 Biggest Movers From Yesterday
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)... 
Via Benzinga
53 Stocks Moving In Tuesday's Mid-Day Session
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to... 
Via Benzinga
Why Clover Health Shares Are Falling
Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower after the company reported a 35 million share common stock offering during Monday's after-hours session... 
Via Benzinga
Here's Why Clover Health Is Falling Today
The Medicare tech company just gave some disappointing news. 
Via The Motley Fool
36 Stocks Moving in Tuesday's Pre-Market Session
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss. Kezar Life Sciences, Inc. (NASDAQ:... 
Via Benzinga
Revenue Growth Makes Clover Health Stock a Strong Buy
A combination of triple-digit growth, expanding provider networks and a low share price make CLOV stock hard to resist. 
Via InvestorPlace
Massively Unchanged Finish Hides Strength in Utilities and Energy
While the market is treading water, the Utilities and Energy sectors finished strong along with other significant option activity. 
Via Talk Markets
DraftKings Stock Has Favorable Long-Term Odds In Its Favor
DKNG stock has shown its fighting spirit already. DraftKings has the opportunity to deliver results and earn Wall Street investors' trust. 
Via InvestorPlace
7 SPACs to Watch After Donald Trump Made Mergers ‘Great Again’
Thanks to Donald Trump's new deal, mergers are hot again. Here are our picks for seven of the best SPACs to watch as the new boom takes off. 
Via InvestorPlace
Topics Government
Exposures Political
Could Clover Be Starting to Make a Comeback?
Clover Health's poor insurance underwriting performance dragged down CLOV stock. However, the company may be making progress. 
Via InvestorPlace
November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch
The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals. SPAC merger votes can act as a catalyst,... 
Via Benzinga
What Investors Should Remember About Clover Health
There is no question Clover Health remains a risky proposition. However, there is one thing about CLOV stock that could make a difference. 
Via InvestorPlace
The Anatomy Of Problem Solving
The Raz Report - Stories of Inspiration On this week's The Raz Report, Jason Raznick speaks with Vivek Garipalli, CEO of Clover Health Investments (NASDAQ: CLOV) on his... 
Via Benzinga
Clover Health Has Long Term Potential with Short Term Volatility
CLOV stock has a legitimate bullish thesis to play out well over time. Meanwhile, investors have to stomach the short term shenanigans. 
Via InvestorPlace
Clover Health Stock Has an Outside Chance of Suprising in Its Upcoing Earnings
It's questionable whether CLOV stock can deliver the better-than-expected results next month it needs in order to move higher. 
Via InvestorPlace
Corsair Gaming Becomes Top WallStreetBets Interest; GameStop, Tesla, Virgin Galactic And These Are Other Top Trends
Corsair Gaming Inc. (NASDAQ:CRSR) has emerged as the most-... 
Via Benzinga
The Outlook of Clover Stock Is Deteriorating
CLOV stock has been a disappointment for many reasons. Given the company's poor fundamentals, it's not worth investing in. 
Via InvestorPlace
Clover Health Stock Is Still Risky, But Speculators Could Consider It
With rising positive sentiment for CLOV stock off recent positive news, speculators may want to give it a crack. 
Via InvestorPlace
Alibaba, GameStop, Tesla See High WallStreetBets Interest And This Stock Tops The Chart Today
Clover Health Investments Corp. (NASDAQ:CLOV) has emerged ... 
Via Benzinga
CLOV Stock: What Reddit Investors Are Saying About Clover Health as Shares Surge Today
Today, improving investor sentiment around Clover Health and CLOV stock is driving retail investors to bid up shares of this de-SPAC play. 
Via InvestorPlace
GameStop Emerges As Top WallStreetBets Interest Heading Into New Week
GameStop Corporation was the most-discussed stock Sunday night on r/WallStreetBets or WSB, a popular Reddit investor forum known for short squeezes. 
Via Talk Markets
Clover Health Stock Reverses Course After Medicare Upgrade: What's Next?
Shares of Clover Health Investments Corp (NASDAQ: CLOV) were trading 7.97% higher at $7.99 Friday afternoon. Chamath Palihapitiya, who helped bring the health care... 
Via Benzinga
Clover Health Has Multiple Catalysts Converging to Move It Forward
CLOV stock owners should be proud to invest in a business that helps seniors get health care while also providing solid shareholder value. 
Via InvestorPlace
The Story’s Not Changing Anytime Soon for Clover Stock
As sell-side bearishness rises, and retail trader excitement fades, the near-term is dim for CLOV stock as Clover remains unprofitable. 
Via InvestorPlace
Here's Why Chamath Sold Some SPCE And Believes In CLOV, SPACs
One of the most polarizing figures in the SPAC investing world has been Chamath Palihapitiya. The noted investor and Social Capital CEO has brought 10 SPACs to market and closed... 
Via Benzinga
Will the Real Clover Health Stock Please Stand Up?
Clover Health trades near its 52-week low of $6.31, well off its 52-week high of $28.85 in June. Will the real CLOV stock please stand up? 
Via InvestorPlace
Clover Health Stock Cannot Create Shareholder Value Without Profits
CLOV stock has a weak balance sheet. Its significant losses outweigh the bullish aspects of its technology-based business model. 
Via InvestorPlace
Clover Health Can Still See a Downdraft Despite Growing Revenue
Clover Health can still see a downdraft. CLOV stock won't rise without a Medicare Advantage business with good medical care ratios. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.